(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -2.37%114.22B | 0.42%77.95B | 5.70%52.86B | -14.89%21.15B | -9.70%116.99B | -16.57%77.62B | -19.61%50.01B | -2.24%24.85B | -5.12%129.55B | 13.51%93.04B |
Special items of operating revenue | -9.17%578.87M | -2.57%424.31M | -22.67%218.04M | 5.96%142.82M | -9.78%637.31M | -10.82%435.49M | -11.56%281.96M | -8.58%134.79M | -5.15%706.4M | -13.69%488.32M |
Operating income | -2.40%114.8B | 0.40%78.37B | 5.54%53.08B | -14.78%21.29B | -9.70%117.62B | -16.54%78.06B | -19.57%50.29B | -2.28%24.98B | -5.12%130.26B | 13.32%93.53B |
Operating expenses | 5.46%-93.12B | 1.26%-63.98B | -4.42%-43.57B | 15.53%-17.52B | 10.92%-98.5B | 16.85%-64.8B | 19.65%-41.72B | 1.15%-20.74B | 3.18%-110.57B | -15.60%-77.93B |
Gross profit | 13.35%21.68B | 8.54%14.39B | 10.96%9.51B | -11.08%3.77B | -2.86%19.13B | -15.01%13.26B | -19.15%8.57B | -7.44%4.24B | -14.72%19.69B | 3.16%15.6B |
Selling expenses | -9.25%-4.21B | -4.33%-2.51B | -10.84%-1.74B | 24.13%-726.41M | 16.25%-3.85B | 31.40%-2.4B | 34.33%-1.57B | 6.74%-957.49M | -12.88%-4.6B | -31.75%-3.5B |
Administrative expenses | 2.11%-8B | 2.10%-5.14B | 1.94%-3.38B | -0.64%-1.65B | -2.99%-8.17B | -4.28%-5.25B | -5.23%-3.45B | -3.25%-1.64B | 2.12%-7.93B | -10.75%-5.04B |
Research and development expenses | -6.78%-5.37B | -10.54%-3.57B | -22.12%-2.33B | -15.20%-985.48M | 6.98%-5.03B | 8.27%-3.23B | 11.13%-1.91B | 3.82%-855.42M | -11.37%-5.41B | -25.48%-3.53B |
Profit from asset sales | 51.13%847M | 281.99%342.7M | -70.09%22.4M | -68.45%25.28M | 206.14%560.44M | -34.11%89.72M | -48.56%74.9M | 556.31%80.12M | -92.81%183.06M | 352.44%136.16M |
Revaluation surplus | 55.99%-314.79M | 107.07%53.78M | 321.73%355.64M | 2,181.54%315.04M | -141.93%-715.32M | -211.56%-760.21M | -123.71%-160.4M | -136.90%-15.14M | 11,089.56%1.71B | 391.24%681.42M |
-Changes in the fair value of other assets | 55.99%-314.79M | 107.07%53.78M | 321.73%355.64M | 2,181.54%315.04M | -141.93%-715.32M | -211.56%-760.21M | -123.71%-160.4M | -136.90%-15.14M | 11,089.56%1.71B | 391.24%681.42M |
Impairment and provision | 18.43%-3.46B | 17.87%-1.52B | -8.35%-1.58B | 56.99%-106.41M | 72.68%-4.24B | 80.67%-1.85B | 83.96%-1.46B | 18.80%-247.42M | -443.99%-15.51B | -731.96%-9.57B |
-Other impairment is provision | 18.43%-3.46B | 17.87%-1.52B | -8.35%-1.58B | 56.99%-106.41M | 72.68%-4.24B | 80.67%-1.85B | 83.96%-1.46B | 18.80%-247.42M | -443.99%-15.51B | -731.96%-9.57B |
Operating interest expense | 0.74%-86.52M | -1.37%-63.18M | 95.96%-1.21M | -119.47%-20.8M | 15.57%-87.17M | 11.78%-62.33M | 33.02%-29.96M | 32.16%-9.48M | -32.77%-103.24M | -30.61%-70.65M |
Special items of operating profit | 83.06%4.05B | 41.39%2.17B | 76.09%1.61B | 105.58%628.95M | -21.76%2.21B | -53.92%1.53B | -44.97%914.89M | -52.32%305.94M | 1.17%2.83B | 115.91%3.33B |
Operating profit | 713.35%4.44B | 272.64%3.66B | 188.01%2.15B | 44.45%1.13B | 92.55%-723.41M | 142.05%983.41M | 118.19%745.84M | -41.93%780.54M | -222.41%-9.71B | -144.47%-2.34B |
Financing cost | 16.84%-1.08B | 29.02%-713.14M | 57.39%-290.52M | 39.56%-220.55M | -15.40%-1.3B | -5.02%-1B | -23.48%-681.8M | -24.11%-364.93M | 39.72%-1.13B | 13.93%-956.63M |
Special items of earning before tax | -222.70%-60.32M | 36.04%-20.58M | -210.26%-35.28M | -213.86%-4.32M | -91.04%49.16M | -118.93%-32.18M | -74.77%32M | -80.23%3.8M | 93.66%548.83M | 63.83%169.98M |
Earning before tax | 266.80%3.29B | 5,584.71%2.93B | 1,797.55%1.82B | 115.22%902.64M | 80.80%-1.98B | 98.29%-53.44M | 102.12%96.03M | -60.78%419.41M | -262.13%-10.29B | -173.52%-3.13B |
Tax | -237.54%-1.14B | -127.71%-513.35M | -57.28%-335.93M | -103.47%-209.57M | -782.13%-337.71M | 64.96%-225.44M | 48.25%-213.58M | 42.98%-103M | 104.58%49.51M | 22.48%-643.42M |
After-tax profit from continuing operations | 193.17%2.15B | 966.88%2.42B | 1,364.42%1.49B | 119.04%693.07M | 77.41%-2.31B | 92.60%-278.88M | 97.62%-117.55M | -64.40%316.41M | -294.46%-10.24B | -210.17%-3.77B |
Earning after tax | 193.17%2.15B | 966.88%2.42B | 1,364.42%1.49B | 119.04%693.07M | 77.41%-2.31B | 92.60%-278.88M | 97.62%-117.55M | -64.40%316.41M | -294.46%-10.24B | -210.17%-3.77B |
Minority profit | 49.17%1.87B | 40.35%1.6B | 2.54%895.98M | 7.39%326.22M | 596.97%1.25B | 74.01%1.14B | 2,572.79%873.79M | 33.68%303.77M | -116.73%-252.22M | -39.24%653.62M |
Profit attributable to shareholders | 108.00%285.16M | 157.99%821.27M | 159.55%590.36M | 2,802.32%366.85M | 64.29%-3.57B | 67.98%-1.42B | 80.06%-991.34M | -98.09%12.64M | -365.76%-9.99B | -288.58%-4.42B |
Basic earnings per share | 107.89%0.018 | 155.56%0.05 | 166.67%0.04 | 2,837.50%0.0235 | 64.38%-0.228 | 69.10%-0.09 | 81.25%-0.06 | -98.11%0.0008 | -356.00%-0.64 | -288.30%-0.2913 |
Diluted earnings per share | 107.89%0.018 | 155.56%0.05 | 166.67%0.04 | 2,837.50%0.0235 | 64.38%-0.228 | 69.10%-0.09 | 81.25%-0.06 | -98.11%0.0008 | -366.67%-0.64 | -288.30%-0.2913 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data